Cargando…

Comparative costs and activity from a sample of UK clinical trials units

BACKGROUND: The costs of medical research are a concern. Clinical Trials Units (CTUs) need to better understand variations in the costs of their activities. METHODS: Representatives of ten CTUs and two grant-awarding bodies pooled their experiences in discussions over 1.5 years. Five of the CTUs pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hind, Daniel, Reeves, Barnaby C., Bathers, Sarah, Bray, Christopher, Corkhill, Andrea, Hayward, Christopher, Harper, Lynda, Napp, Vicky, Norrie, John, Speed, Chris, Tremain, Liz, Keat, Nicola, Bradburn, Mike
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414193/ https://www.ncbi.nlm.nih.gov/pubmed/28464930 http://dx.doi.org/10.1186/s13063-017-1934-3

Ejemplares similares

UK-based, multisite, prospective cohort study of small bowel obstruction in acute surgical services: National Audit of Small Bowel Obstruction (NASBO) protocol
por: Lee, Matthew J, et al.
Publicado: (2017)

Clinical trial recruiters’ experiences working with trial eligibility criteria: results of an exploratory, cross-sectional, online survey in the UK
por: Cragg, William J., et al.
Publicado: (2021)

Correction to: Clinical trial recruiters’ experiences working with trial eligibility criteria: results of an exploratory, cross-sectional, online survey in the UK
por: Cragg, William J., et al.
Publicado: (2021)

Process evaluation and exploration of telehealth in motor neuron disease in a UK specialist centre
por: Hobson, Esther, et al.
Publicado: (2019)

Design, planning and implementation lessons learnt from a surgical multi-centre randomised controlled trial
por: Biggs, Katie, et al.
Publicado: (2019)

Cardiovascular magnetic resonance in emergency patients with multivessel disease or unobstructed coronary arteries: a cost-effectiveness analysis in the UK
por: Stokes, Elizabeth A, et al.
Publicado: (2019)

Hypertonic saline (HS) for acute bronchiolitis: Systematic review and meta-analysis
por: Maguire, Chin, et al.
Publicado: (2015)

How Cancer Research UK is adapting to adaptive designs
por: Hearn, Julie, et al.
Publicado: (2011)

What are the methodological designs of nihr funded clinical trials? Going beyond routine data collection
por: Young, Amanda, et al.
Publicado: (2015)

Cost-Effectiveness of Haemorrhoidal Artery Ligation versus Rubber Band Ligation for the Treatment of Grade II–III Haemorrhoids: Analysis Using Evidence from the HubBLe Trial
por: Alshreef, Abualbishr, et al.
Publicado: (2017)

Study feasibility - visualising the operationalisation of studies from early conception stage
por: Zwierska, Irena, et al.
Publicado: (2015)

Using telehealth in motor neuron disease to increase access to specialist multidisciplinary care: a UK-based pilot and feasibility study
por: Hobson, Esther V, et al.
Publicado: (2019)

Costs and Treatment Pathways for Type 2 Diabetes in the UK: A Mastermind Cohort Study
por: Eibich, Peter, et al.
Publicado: (2017)

Prospectively predicting Pseudomonas aeruginosa infection/s using routine data from the UK cystic fibrosis register
por: Totton, Nikki, et al.
Publicado: (2021)

Cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis: a systematic review and meta-analysis
por: Hind, Daniel, et al.
Publicado: (2014)

Participation bias in the UK Biobank distorts genetic associations and downstream analyses
por: Schoeler, Tabea, et al.
Publicado: (2023)

An economic evaluation of the healthcare cost of tinnitus management in the UK
por: Stockdale, David, et al.
Publicado: (2017)

Early use of oral semaglutide in the UK: A cost-effectiveness analysis versus continuing metformin and SGLT-2 inhibitor therapy
por: Ren, Hongye, et al.
Publicado: (2023)

A longitudinal study to assess the frequency and cost of antivascular endothelial therapy, and inequalities in access, in England between 2005 and 2015
por: Hollingworth, William, et al.
Publicado: (2017)

Evaluation of the long‐term cost‐effectiveness of once‐weekly semaglutide versus dulaglutide for treatment of type 2 diabetes mellitus in the UK
por: Viljoen, Adie, et al.
Publicado: (2018)

Evaluation of the Cost-Effectiveness of Iron Formulations for the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease in the UK
por: Aksan, Aysegül, et al.
Publicado: (2021)

Evaluating the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment of Type 2 Diabetes in the UK
por: Johansen, Pierre, et al.
Publicado: (2020)

Evaluating the Cost-Effectiveness of Once-Weekly Semaglutide 1 mg Versus Empagliflozin 25 mg for Treatment of Patients with Type 2 Diabetes in the UK Setting
por: Capehorn, Matthew, et al.
Publicado: (2021)

The long-term cost-effectiveness of once-weekly semaglutide 1 mg vs. dulaglutide 3 mg and 4.5 mg in the UK
por: Viljoen, Adie, et al.
Publicado: (2022)

The healthcare costs of heart failure during the last five years of life: A retrospective cohort study
por: Hollingworth, William, et al.
Publicado: (2017)

A focus group study of older Chinese people with CVD patients in the North West of the UK
por: Speed, Shaun, et al.
Publicado: (2021)

Accuracy of efficient data methods to determine the incidence of hospital-acquired thrombosis and major bleeding in medical and surgical inpatients: a multicentre observational cohort study in four UK hospitals
por: Horner, Daniel, et al.
Publicado: (2023)

Model-based cost-effectiveness analysis of B-type natriuretic peptide-guided care in patients with heart failure
por: Mohiuddin, Syed, et al.
Publicado: (2016)

Evaluating the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide 1 mg Versus Liraglutide 1.8 mg: A Health Economic Analysis in the UK
por: Evans, Marc, et al.
Publicado: (2023)

Cost Effectiveness of Secukinumab for the Treatment of Active Psoriatic Arthritis in the UK
por: Buchanan, Vanessa, et al.
Publicado: (2018)

Psychiatry in the UK: an overview
por: Banks, Vicky, et al.
Publicado: (2011)

Cost Effectiveness of Gemtuzumab Ozogamicin in the First-Line Treatment of Acute Myeloid Leukaemia in the UK
por: Russell-Smith, T. Alexander, et al.
Publicado: (2021)

Approaches to multiplicity in publicly funded pragmatic randomised controlled trials: a survey of clinical trials units and a rapid review of published trials
por: Pike, Katie, et al.
Publicado: (2022)

Systematic review of clinical decision support interventions with potential for inpatient cost reduction
por: Fillmore, Christopher L, et al.
Publicado: (2013)

Being healthy: A Grounded Theory study of help seeking behaviour among Chinese elders living in the UK
por: Liu, Zhenmi, et al.
Publicado: (2014)

Once‐weekly semaglutide versus insulin aspart for the treatment of type 2 diabetes in the UK: A long‐term cost‐effectiveness analysis based on SUSTAIN 11
por: Evans, Marc, et al.
Publicado: (2022)

Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK
por: Emery, Paul, et al.
Publicado: (2018)

Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme
por: Bain, Stephen C., et al.
Publicado: (2019)

Interventions for the prevention or treatment of epidural-related maternal fever: a systematic review and meta-analysis
por: Cartledge, Anna, et al.
Publicado: (2022)

Association of Peripheral Interleukin-6 with Global Cognitive Decline in Non-demented Adults: A Meta-Analysis of Prospective Studies
por: Bradburn, Steven, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_s7f1vvm37go03iah0ahle4a9md